Tuesday , January 16 2018
Home / David L. Joffe, BSPharm, CDE, FACA (page 3)

David L. Joffe, BSPharm, CDE, FACA

David L. Joffe, BSPharm, CDE, FACA

(Editor-in-Chief Diabetes In Control) A graduate of University of Kentucky College of Pharmacy, he has practiced in the Tampa Bay area since 1986, has been providing diabetes and cardiovascular care in Tampa Bay since 1995, and spent 2 years as an Eckerd Patient Care Pharmacist managing over 100 diabetes patients. Dave currently sees patients in over 30 primary care and endocrinologists offices.

Nov. 7, 2017

Our publisher got a chance to sit down with Dr Aaron Vinik at a recent AACE meeting. For those of you who have been following our publication for the past 18 years, you have seen Dr. Vinik’s name repeatedly. He was one of the first “legends in diabetes” to have …

Read More »

Nov. 4, 2017

Over the years we have heard that there are more than two types of diabetes. In fact we have carried articles in the past stating that Alzheimer’s is really a form of diabetes. These monikers often disappear in a short time period and are forgotten. This week we bring you …

Read More »

Oct. 31, 2017

A couple of weeks ago we were starting an in depth clinical look at Metabolomics. In part one we started getting into the definitions of the science and the effects this has on insulin resistance and and diabetes. Part two added more information, and now in part three we start to look at …

Read More »

Oct. 28, 2017

The use of GLP-1 agonists just got easier. For the past couple of years, if your patient’s formulary paid for Trulicity, they had an easy time administering their dose. Adherence was improved because no mixing was necessary and you didn’t have to stare at the needle. Now Bydureon joins the …

Read More »

Oct. 24, 2017

It is not unusual for many of us to begin to take things about diabetes for granted and forget to share some information with our patients. After showing many people how to use an insulin pen, medical professionals often will forget little things like taking the cap off of the …

Read More »

Oct 21, 2017

This week insulin takes a front row in treating diabetes with the information on a new super rapid insulin. This insulin, discussed in this week’s item 2,  gives flexibility at meal time that has been lacking for a lot of patients. Also, as Animas leaves the insulin pump market, a …

Read More »

Oct 17, 2017

There was a time when diabetes was defined as a simple lack of insulin, and when 14 year old Leonard Thompson received the first injection of insulin as a treatment for type 1 diabetes in Toronto, Ontario, on January 11, 1922,  supposedly the cure was found. We know almost 100 …

Read More »

Oct 12, 2017

When we talk about children and young adults and type 1 diabetes, we often put most of our focus on preventing hypoglycemia. This is likely the one symptom of diabetes that keeps many patients and their parents from reaching the prescribed target. Part of this occurs because of the child’s irregular …

Read More »

Oct. 10, 2017

For years, we have pretty much put every patient with diabetes on a statin. In fact, HEDIS guidelines mandate that Medicare patients have to be on a statin in order for a plan to get a 5-star rating. But we all know the potential dangers that we expose patients to …

Read More »

Oct. 7, 2017

I first got my CDE back in 2004. Before that I was the proud holder of a certificate from the Lifescan Pharmacist Diabetes education program that they were offering to us in Milpitas, CA. After I became a CDE, I desperately wanted to become a pump trainer. I talked to …

Read More »